Parity improves anti-tumor immunity in breast cancer patients-Reference-Cited by-同舟云学术

Parity improves anti-tumor immunity in breast cancer patients

Published:2017-09-08 Issue:62 Volume:8 Page:104981-104991
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Krause Anna-Lena¹,Schuetz Florian²,Boudewijns Marc²,Pritsch Maria¹,Wallwiener Markus²,Golatta Michael²,Rom Joachim²,Heil Joerg²,Sohn Christof²,Schneeweiss Andreas²,Beckhove Philipp¹³,Domschke Christoph²

Affiliation:

1. Translational Immunology Division, German Cancer Research Center (DKFZ), Heidelberg, Germany

2. Department of Gynecology and Obstetrics, Heidelberg University Hospital, National Center for Tumor Diseases (NCT), Heidelberg, Germany

3. Regensburg Center for Interventional Immunology (RCI) and University Medical Center of Regensburg, Regensburg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clustering of HR + /HER2− breast cancer in an Asian cohort is driven by immune phenotypes;Breast Cancer Research;2024-04-22

2. Clustering of HR+/HER2- breast cancer in an Asian cohort is driven by immune phenotypes;2023-12-08

3. The Impact of Reproductive Factors on the Risk of Breast Cancer by ER/PR and HER2: A Multicenter Case-Control Study in Northern and Eastern China;The Oncologist;2022-01-01

4. Rethinking the carcinogenesis of breast cancer: The theory of breast cancer as a child deficiency disease or a pseudo semi-allograft;Medical Hypotheses;2018-11

5. Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients;Clinical Epidemiology;2018-08